Nobl Laboratories, Inc. – Trademark Portfolio
Entity Type: 03
Nobl Laboratories, Inc. holds 26 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 22 filings in this category. The portfolio also extends into Class 16 (Paper Goods) across 4 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include TOXIVAC. The owner is based in Sioux Center, IA.
204-3rd St., NW.
Sioux Center, IA 51250
Showing of trademarks Trademarks
Trademark Classifications
Nobl Laboratories, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Nobl Laboratories, Inc. have?
Nobl Laboratories, Inc. has 26 U.S. trademarks filed with the USPTO. Of these, 1 registered, 11 abandoned, 14 cancelled.
What trademark classes does Nobl Laboratories, Inc. file in?
Nobl Laboratories, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 16 (Paper Goods), Class 42 (Computer & Scientific), Class 1 (Chemicals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Nobl Laboratories, Inc.'s most well-known trademarks?
Nobl Laboratories, Inc.'s registered trademark portfolio includes well-known marks such as TOXIVAC. These are among 1 currently registered trademark in the portfolio.
What is Nobl Laboratories, Inc.'s trademark registration success rate?
Nobl Laboratories, Inc. has a 4% trademark registration rate, with 1 out of 26 resolved applications resulting in successful registration. Currently, 0 applications are pending review.